- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 98.21M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $235.86M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $263.21M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $39.86M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $50.82M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $27.62M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $23.44M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $98.34M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $94.36M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $303.86M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $334.3M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $327.32M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $351.15M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 96.49M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $83K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$6.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $223.87M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $230.76M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $7.96M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $5.23M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.29M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$13.19M |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |